NasdaqGS - Nasdaq Real Time Price USD
InMode Ltd. (INMD)
As of 1:20 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
416,626.00
492,048.00
454,271.00
357,565.00
206,107.00
Cost of Revenue
73,881.00
80,708.00
73,485.00
53,592.00
30,849.00
Gross Profit
342,745.00
411,340.00
380,786.00
303,973.00
175,258.00
Operating Expense
208,685.00
215,680.00
182,932.00
136,496.00
102,417.00
Operating Income
134,060.00
195,660.00
197,854.00
167,477.00
72,841.00
Net Non Operating Interest Income Expense
30,547.00
21,607.00
3,612.00
525.00
3,291.00
Pretax Income
164,607.00
217,267.00
201,466.00
168,002.00
76,132.00
Tax Provision
15,408.00
19,348.00
39,946.00
2,928.00
1,107.00
Net Income Common Stockholders
149,199.00
197,919.00
161,520.00
164,971.00
75,030.00
Diluted NI Available to Com Stockholders
149,199.00
197,919.00
161,520.00
164,971.00
75,030.00
Basic EPS
2.16
2.37
1.96
2.03
1.04
Diluted EPS
2.11
2.30
1.89
1.92
0.89
Basic Average Shares
83,875.84
83,534.00
82,482.00
81,445.00
72,114.00
Diluted Average Shares
86,098.08
85,954.00
85,404.00
86,017.00
84,184.00
Total Operating Income as Reported
134,060.00
195,660.00
197,854.00
167,477.00
72,841.00
Total Expenses
282,566.00
296,388.00
256,417.00
190,088.00
133,266.00
Net Income from Continuing & Discontinued Operation
149,199.00
197,919.00
161,520.00
164,971.00
75,030.00
Normalized Income
149,199.00
197,919.00
161,520.00
164,971.00
75,030.00
Interest Income
--
21,607.00
3,612.00
525.00
3,291.00
Net Interest Income
30,547.00
21,607.00
3,612.00
525.00
3,291.00
EBIT
134,060.00
195,660.00
197,854.00
167,477.00
72,841.00
EBITDA
134,653.00
196,283.00
198,534.00
167,994.00
73,257.00
Reconciled Cost of Revenue
73,881.00
80,708.00
73,485.00
53,592.00
30,849.00
Reconciled Depreciation
593.00
623.00
680.00
517.00
416.00
Net Income from Continuing Operation Net Minority Interest
149,199.00
197,919.00
161,520.00
164,971.00
75,030.00
Normalized EBITDA
134,653.00
196,283.00
198,534.00
167,994.00
73,257.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 8/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EW Edwards Lifesciences Corporation
68.00
+1.48%
NVCR NovoCure Limited
15.72
+3.56%
TMDX TransMedics Group, Inc.
81.22
-0.91%
NARI Inari Medical, Inc.
48.54
+0.29%
PRCT PROCEPT BioRobotics Corporation
93.44
+3.82%
DXCM DexCom, Inc.
70.57
+0.12%
SMLR Semler Scientific, Inc.
31.40
+6.88%
NNOX Nano-X Imaging Ltd.
5.74
+1.23%
IRTC iRhythm Technologies, Inc.
76.87
+6.12%
SYK Stryker Corporation
363.44
+2.01%